A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
Harada-Shiba, Mariko, Ali, Shazia, Gipe, Daniel A., Gasparino, Evelyn, Son, Vladimir, Zhang, Yi, Pordy, Robert, Catapano, Alberico L.Volume:
314
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2020.10.013
Date:
December, 2020
File:
PDF, 159 KB
2020